782TiP Reduced frequency immune checkpoint inhibition in cancers (REFINE): A multi-arm phase II trial testing reduced intensity immunotherapy in different cancers
| Autor: | Merrick, S., Nankivell, M., Griffiths, T., Hudson, W., Clarke, C.S., Bray, G., Forcat, S., Campos, M., Bryant, H., Quartagno, M., Langley, R., Pickering, L.M., Vasudev, N.S., Gilbert, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S898-S898 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|